2022 Fall Conference | C20 - Interventional Headache Management: Botulinum Toxin, Nerve Blocks, Trigger Point Injections, Surgery, and Neuromodulation

Date Saturday 10/29/22

Time 01:00 PM - 05:00 PM PDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Half-Day Course

Director(s) Rashmi B. Halker Singh, MD, FAAN, Hope M. O'Brien, MD, MBA, FAAN

Topic(s) Headache

Learning Objectives Participants should become familiar with the indications of interventional treatment of headache which include invasive and non-invasive options. Invasive techniques include peripheral cranial nerve blocks, trigger point injections and onabotulinumtoxinA. Non-invasive treatment include the use of neurmodulation devices. Participants will gain hands on experience with these techniques during break-out sessions. The hands-on portion of this program will not be available in the virtual platform.

CME Available 3.50 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement

Program Level Introductory

Recommended Audience Fellow, Resident, General Neurologist, Advanced Practice Provider

Teaching Styles Didactic, Audience Participation, Other

Program Materials

Event Timeline
01:00 PM - 01:05 PM PDT	Introduction	Welcome Hope M. O'Brien, MD, MBA, FAAN
01:05 PM - 01:25 PM PDT	Speaker	Onabotulinumtoxin A Brinder Vij, MD
01:25 PM - 01:45 PM PDT	Speaker	Nerve Blocks - GONB, LONB, SONB, STNB, SPG, Trigger Point Injections Cynthia E. Armand, MD
01:45 PM - 02:05 PM PDT	Speaker	Surgical Intervention for Migraine Paul G. Mathew, MD, DNBPAS, FAAN, FAHS, FAAN
02:05 PM - 02:25 PM PDT	Speaker	Invasive Treatments of Migraine in Pediatrics and Adolescents Marielle K. Samaha, MD, FAHS, FAAN, FAAN
02:25 PM - 02:45 PM PDT	Speaker	Neuromodulation for Migraine Acute Treatment Deena Kuruvilla, MD
02:45 PM - 03:05 PM PDT	Speaker	Neuromodulation for Migraine Prevention Michael J. Marmura, MD, FAAN
03:05 PM - 03:20 PM PDT	Q&A	Questions and Answers
03:20 PM - 05:00 PM PDT	Speaker	Breakout Rotations Rashmi B. Halker Singh, MD, FAAN, Hope M. O'Brien, MD, MBA, FAAN, Cynthia E. Armand, MD, Brinder Vij, MD, Deena Kuruvilla, MD, Marielle K. Samaha, MD, FAHS, FAAN, FAAN, Paul G. Mathew, MD, DNBPAS, FAAN, FAHS, FAAN, Michael J. Marmura, MD, FAAN

Faculty Disclosures
Rashmi B. Halker Singh, MD, FAAN	Dr. Halker Singh has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Halker Singh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie. Dr. Halker Singh has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Neurology & Neuroscience Reports. Dr. Halker Singh has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Headache Journal. Dr. Halker Singh has received publishing royalties from a publication relating to health care. Dr. Halker Singh has received personal compensation in the range of $5,000-$9,999 for serving as a CME speaker with Pri-med. Dr. Halker Singh has received personal compensation in the range of $500-$4,999 for serving as a CME speaker with Medscape.
Hope M. O'Brien, MD, MBA, FAAN	The institution of Dr. O'Brien has received personal compensation in the range of $0-$499 for serving as a Consultant for Guidepoint. The institution of Dr. O'Brien has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. The institution of Dr. O'Brien has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pfizer. The institution of Dr. O'Brien has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. An immediate family member of Dr. O'Brien has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Astra Zenica. The institution of Dr. O'Brien has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. The institution of Dr. O'Brien has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Eli Lilly. The institution of Dr. O'Brien has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Scilex. The institution of Dr. O'Brien has received research support from Abbvie. The institution of Dr. O'Brien has received research support from Eli Lilly. Dr. O'Brien has received publishing royalties from a publication relating to health care. Dr. O'Brien has a non-compensated relationship as a Accreditation Council Member with UCNS that is relevant to AAN interests or activities.
Brinder Vij, MD	Dr. Vij has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie/Allergan. Dr. Vij has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biohaven .
Deena Kuruvilla, MD	Dr. Kuruvilla has received personal compensation for serving as an employee of Cefaly. Dr. Kuruvilla has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theranica. Dr. Kuruvilla has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Kuruvilla has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for allergan. Dr. Kuruvilla has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Lilly. Dr. Kuruvilla has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for amgen. Dr. Kuruvilla has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for allergan/abbvie. Dr. Kuruvilla has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Healthline . Dr. Kuruvilla has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Abbvie/Allergan. Dr. Kuruvilla has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for ESTES, INGRAM, FOELS & GIBBS, P.A.
Cynthia E. Armand, MD	Dr. Armand has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CE Interactive. Dr. Armand has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Armand has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Armand has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology.
Marielle K. Samaha, MD, FAHS, FAAN, FAAN	Dr. Samaha has received personal compensation in the range of $500-$4,999 for serving as a Consultant for theranica. Dr. Samaha has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for AAN . The institution of Dr. Samaha has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for AAP.
Paul G. Mathew, MD, DNBPAS, FAAN, FAHS, FAAN	Dr. Mathew has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie/Allergan. Dr. Mathew has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lilly. Dr. Mathew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Mathew has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biohaven/Pfizer. Dr. Mathew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. Dr. Mathew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Impel. Dr. Mathew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Upsher Smith. Dr. Mathew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Mathew has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie.
Michael J. Marmura, MD, FAAN	Dr. Marmura has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Marmura has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Axsome. Dr. Marmura has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Marmura has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theranica. Dr. Marmura has stock in Curelator. The institution of Dr. Marmura has received research support from Teva. The institution of Dr. Marmura has received research support from AbbVie. Dr. Marmura has received publishing royalties from a publication relating to health care. Dr. Marmura has received publishing royalties from a publication relating to health care. Dr. Marmura has received publishing royalties from a publication relating to health care.

��ɫ��

��ɫ��